人参、黄连及其药对治疗糖尿病研究进展  

Treatment of diabetes about Ginseng,Rhizoma Coptidis and huanglian-renshen pair

作　　者：张美双[1] 李志成[1] 田淋淋 胡学生 孙佳明[1] 张辉[1] 

机构地区：[1]长春中医药大学中医药与生物工程研发中心,长春130117

出　　处：《长春中医药大学学报》2016年第3期656-658,共3页Journal of Changchun University of Chinese Medicine

基　　金：吉林省科技发展计划重点科技成果转化项目(20130303108YY)

摘　　要：现代药理研究表明,人参具有调节免疫力、改善微循环、调节血糖等作用,其中人参皂苷在治疗和改善糖尿病及其并发症方面具有显著效果;黄连具有抗氧化、抗病毒、正性肌力及降压与降糖的作用,分离出来的生物碱主要有小檗碱、药根碱等,其中小檗碱的含量最高,其降糖作用也最好。Modern pharmacological research show that ginseng has regulating immunity,improving microcirculation,regulate blood sugar,and so on,including ginseng saponin in treatment and improvement of diabetes and its complications has the remarkable effect. Coptis chinensis with antioxidant,antiviral,positive inotropic and step-down and hypoglycemic effect,the separated alkaloids mainly berberine,medicine root base,etc.,of which the highest content of berberine,its hypoglycemic effect is best.

关 键 词：人参 黄连 药对 糖尿病 

分 类 号：R255.4[医药卫生—中医内科学]